Health and Wellbeing
The Health and Wellbeing theme covers the study, teaching and training of the psychological processes of health, illness and health care, and their application to the promotion and maintenance of health, the analysis and improvement of the health care system and health policy formation, and the prevention of illness and disability and the enhancement of outcomes of those who are ill or disabled.
Areas of expertise include the health psychology, and the study of health-related behaviour change (e.g. smoking cessation), pain, psychometrics, dementia, eating disorders and intellectual disabilities. For more details, see the links to the Health psychology research group, the Centre for health service research in intellectual disabilities and the Psychometric laboratory.
Teaching includes the Health Psychology unit within the department’s clinical psychology doctorate, the Clinical and Health Psychology undergraduate second year option and contributions to the Health Psychology MSc (hosted by the Department of Epidemiology and Public Health). Training includes UCL Partner’s course, Behaviour Change for Health Professionals: An introductory course.
The INfluENCE project: Improving communication with the public about antivirals and vaccination during the next pandemic
PI's: Helena Rubinstein and Susan Michie are working in collaboration with Public Health England, the University of Southampton, the University of Northumbria, King’s College, London and Imperial College.
This 2 year project has received £506,878 from the Department of Health via the Policy Research Programme.
During the 2009 H1N1 pandemic, many people did not seek care quickly enough, failed to take a full course of antivirals despite being authorised to receive them, and were not vaccinated. The study is being conducted in advance of a future influenza pandemic to inform the Department of Health about their future communication strategies and campaigns in the event of a pandemic influenza outbreak. The research aims to (i) identify barriers to and enablers of the uptake of vaccination and antiviral medicines in future pandemic scenarios and (ii) informed by this, develop theory- and evidence-based messages to promote uptake.
Focus groups and interviews will be conducted with the general public and with health professionals to better understand the rationale for being vaccinated and taking antiviral medicines during a pandemic outbreak and a survey with the general public will be conducted to evaluate theory- and evidence-based messages that promote positive responses to pandemic vaccination and antivirals.
A novel treatment for cannabis dependence?
PI: Professor Val Curran & Dr. Celia Morgan
Research Associates: Dr Tom Freeman & Chandni Hindocha
Collaborator: Dr. Paul Morrison, IoP
£1.3million Medical Research Council
More people are dependent on cannabis than any other illicit drug – at least 18 million worldwide. In Europe, 1% of all adults and nearly 2% of 14-17 year olds are addicted to cannabis. Rates of cannabis dependence have increased markedly over recent years alongside changes in the ingredients of cannabis available on the. Among UK first-time drug treatment clients, cannabis is now the primary addiction in 28% of those entering drug treatment, second only to heroin (41%).
The demand for cannabis treatment has more than doubled since 2001 (UNODC World Drug Report 2010). At present, clinicians rely on psychological treatments which have very limited effectiveness. If we found a safe, effective medicine this could improve treatment in a similar way that various medicines have improved rates of stopping tobacco use. It would also impact on educational/vocational achievement and illegal behaviour, and reduce young people’s risks of cannabis-associated mental health problems (e.g. schizophrenia, depression).
This project will first determine which dose of a novel pharmacological treatment is best in treating cannabis dependence before fully evaluating its efficacy.
We are inviting participants to take part who are at least 16 years old, meet clinical criteria for cannabis dependence and would like to stop using the drug.
Beard, E., McNeill, A., Aveyard, P., Fidler, J., Michie, S., & West, R. (2013) Association between use of nicotine replacement therapy for harm reduction and smoking cessation: A prospective study of English smokers. Tobacco Control, 22,118-122.
Tillmann, T., Krishnadas, R., Cavanagh, J., & Petrides, K. V. (2013) Possible rheumatoid arthritis subtypes in terms of rheumatoid factor, depression, diagnostic delay and emotional expression: an exploratory case-control study. Arthritis Research and Therapy, vol15(2) doi: 10.1016/j.ridd.2012.12.017.
Page last modified on 11 dec 13 13:11